Loading clinical trials...
Loading clinical trials...
MT2011-21C Laronidase (Aldurazyme TM) Enzyme Replacement Therapy (ERT) With Hematopoietic Stem Cell Transplantation (HSCT) for Hurler Syndrome (MPS IH).
Conditions
Interventions
Laronidase
Locations
1
United States
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States
Start Date
March 28, 2012
Primary Completion Date
May 1, 2018
Completion Date
May 1, 2018
Last Updated
September 27, 2018
NCT03333200
NCT06149403
NCT04571970
NCT02294877
NCT04088734
NCT01372228
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions